GGrantIndex
← Leaderboards

Richard S Garfein

University Of California, San Diego

$9,266,106
Attributed
$10,770,209
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY200625
$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,333,619 · 6
CDC$436,590 · 1

By mechanism

R01$5,437,947 · 2
U01$3,128,997 · 1
R56$1,351,751 · 2
UR6$436,590 · 1
R21$414,924 · 1

Top collaborators

Most similar at University Of California, San Diego

Same institution · by research overlap

Others in their field

Top investigators on “Tuberculosis

Research focus

TuberculosisMycobacterium TuberculosisPharmaceutical PreparationsPersonsTransmission ProcessUnited States National Institutes Of HealthReportingBaseIncidenceMexicoHiv InfectionsCitiesCaliforniaCostSamplingHome EnvironmentFundingParticipantUniversitiesInfectionMeetingsCollaborationsTravelCohort

Grant awards (21)

Rapid Detection of TB from Blood using Cell-Free DNA and CRISPR$718,939
R01 · FY2025 · AI
Rapid Detection of TB from Blood using Cell-Free DNA and CRISPR$739,826
R01 · FY2024 · AI
Rapid Detection of TB from Blood using Cell-Free DNA and CRISPR$795,192
R01 · FY2023 · AI
A Novel Point-of-Care Assay for Diagnosing TB from Blood using Exosomes$754,249
R56 · FY2022 · AI
Cell Phone Video Directly Observed Therapy to Monitor Short Course LTBI Treatment$620,477
U01 · FY2019 · AI · contact PI
Cell Phone Video Directly Observed Therapy to Monitor Short Course LTBI Treatment$630,680
U01 · FY2018 · AI · contact PI
Cell Phone Video Directly Observed Therapy to Monitor Short Course LTBI Treatment$628,162
U01 · FY2017 · AI · contact PI
Cell Phone Video Directly Observed Therapy to Monitor Short Course LTBI Treatment$600,963
U01 · FY2016 · AI · contact PI
Cell Phone Video Directly Observed Therapy to Monitor Short Course LTBI Treatment$648,715
U01 · FY2015 · AI · contact PI
Drug tourism to Mexico: Impact of Mexicos new drug law on HIV-HCV-TB in US IDUs$568,934
R01 · FY2015 · DA · contact PI
Drug tourism to Mexico: Impact of Mexicos new drug law on HIV-HCV-TB in US IDUs$682,769
R01 · FY2014 · DA · contact PI
Drug tourism to Mexico: Impact of Mexicos new drug law on HIV-HCV-TB in US IDUs$616,726
R01 · FY2013 · DA · contact PI
Drug tourism to Mexico: Impact of Mexicos new drug law on HIV-HCV-TB in US IDUs$72,075
R01 · FY2013 · DA · contact PI
Drug tourism to Mexico: Impact of Mexicos new drug law on HIV-HCV-TB in US IDUs$606,420
R01 · FY2012 · DA · contact PI
Drug tourism to Mexico: Impact of Mexicos new drug law on HIV-HCV-TB in US IDUs$32,550
R01 · FY2012 · DA · contact PI
Drug tourism to Mexico: Impact of Mexicos new drug law on HIV-HCV-TB in US IDUs$604,516
R01 · FY2011 · DA · contact PI
Mobile Phone-Based Video Directly Observed Therapy for Tuberculosis$180,203
R21 · FY2011 · AI · contact PI
Mobile Phone-Based Video Directly Observed Therapy for Tuberculosis$234,721
R21 · FY2010 · AI · contact PI
Cross-Border Dynamics of MDR/XDR-TB Epidemiology by HIV Status in Tijuana, Mexico$597,502
R56 · FY2009 · AI · contact PI
Reducing Sexual HIV Risk among Methamphetamine-Using MSM in San Diego, CA$218,295
UR6 · FY2007 · PS · contact PI
Reducing Sexual HIV Risk among Methamphetamine-Using MSM in San Diego, CA$218,295
UR6 · FY2006 · PS · contact PI